Acurion: Funding, Investors & Team (Sep 2026)
Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images to inform oncology treatment decisions. The company’s core product, OncoGaze™, analyzes digitized tumor biopsy slides to identify clinically relevant molecular features such as homologous recombination deficiency that guide therapy selection more rapidly than conventional genomic testing. Acurion’s platform integrates into existing clinical workflows to support earlier precision medicine decisions for cancer care and is being expanded to detect additional biomarkers across various tumor types. The company collaborates with research and clinical partners to advance applications of its machine learning technology in oncology and related areas.
Acurion has raised $4.3M across 1 funding round on record, the most recent a Seed of $4.3M announced in Apr 2026.
That round is below the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Acurion Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Acurion Funding Rounds
Acurion Founders and Leadership Team
Contact details for the Acurion team: 1 of 1 has an email address on file.
Start 14-day free trial →Acurion Funding Compared to Other Artificial Intelligence Startups
Acurion's latest round of $4.3M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acurion in Artificial Intelligence and San Diego
Companies Similar to Acurion
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Acurion Funding FAQs
What does Acurion do?
Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images to inform oncology treatment decisions. The company’s core product, OncoGaze™, analyzes digitized tumor biopsy slides to identify clinically relevant molecular features such as homologous recombination deficiency that guide therapy selection more rapidly than conventional genomic testing. Acurion’s platform integrates into existing clinical workflows to support earlier precision medicine decisions for cancer care and is being expanded to detect additional biomarkers across various tumor types. The company collaborates with research and clinical partners to advance applications of its machine learning technology in oncology and related areas.
How much funding has Acurion raised?
Acurion has raised $4.3M across 1 round on record. The most recent is a Seed of $4.3M announced in Apr 2026.
When did Acurion last raise funding?
Acurion's most recent funding round on record is a Seed of $4.3M, announced in Apr 2026.
Who founded Acurion?
FundedIQ lists Rick Fultz (Founder) at Acurion.
Where is Acurion headquartered?
Acurion is based in San Diego, California, United States.
How many employees does Acurion have?
Acurion is in the 11-50 employee band.
How does Acurion's funding compare to other Artificial Intelligence startups?
Acurion's latest round of $4.3M is below the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Acurion Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acurion is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.